Atara Biotherapeutics Inc - ESG Rating & Company Profile powered by AI
The report of Atara Biotherapeutics Inc uses information from across the internet and also from public documents by Atara Biotherapeutics Inc. If you work at Atara Biotherapeutics Inc and you wish to licence your ESG aseessment, please contact us. Scroll down to the end of this page for potential risks for Atara Biotherapeutics Inc based on industry, location and size.
Atara Biotherapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.3; made up of an environmental score of 6.0, social score of 4.8 and governance score of 8.0.
6.3
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 402 | United Laboratories International Holdings Ltd | 6.4 | High |
| 402 | Zenabis Global Inc | 6.4 | High |
| 427 | Atara Biotherapeutics Inc | 6.3 | High |
| 427 | Calliditas Therapeutics AB | 6.3 | High |
| 427 | Carna Biosciences Inc | 6.3 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Atara Biotherapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Atara Biotherapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Atara Biotherapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Atara Biotherapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Atara Biotherapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Atara Biotherapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Atara Biotherapeutics Inc offer flexible work?
Sign up for free to unlockDoes Atara Biotherapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Atara Biotherapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Atara Biotherapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Atara Biotherapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Atara Biotherapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Atara Biotherapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Atara Biotherapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Atara Biotherapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Atara Biotherapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Atara Biotherapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Atara Biotherapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Atara Biotherapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Atara Biotherapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Atara Biotherapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Atara Biotherapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Atara Biotherapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Atara Biotherapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Atara Biotherapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Atara Biotherapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Atara Biotherapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Atara Biotherapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Atara Biotherapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Atara Biotherapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Atara Biotherapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Atara Biotherapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Atara Biotherapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Atara Biotherapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Atara Biotherapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Atara Biotherapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Atara Biotherapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferative disease, as well as hematologic and solid tumors, including nasopharyngeal carcinoma. The company is also developing next-generation CAR T immunotherapies for patients with hematologic malignancies and solid tumors, including ATA2271 and ATA3271 for mesothelin; and ATA2431 and ATA3219 for B-cell malignancies, as well as ATA188 for the treatment of multiple sclerosis. In addition, it develops ATA368 program for patients with human papillomavirus associated cancers. Atara Biotherapeutics, Inc. has a license agreement with Memorial Sloan Kettering Cancer Center; license, and research and development collaboration agreement with QIMR Berghofer Medical Research Institute; and strategic collaboration with H. Lee Moffitt Cancer Center, as well as Bayer AG for mesothelin-targeted CAR T-cell therapies for solid tumors. The company was incorporated in 2012 and is headquartered in South San Francisco, California.